Tg Therapeutics (TGTX) Revenue Growth (1y) (2018 - 2026)
Tg Therapeutics (TGTX) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | 69.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.56% |
| Dec 31, 2025 | 78.00% |
| Sep 30, 2025 | 92.79% |
| Jun 30, 2025 | 92.13% |
| Mar 31, 2025 | 90.40% |
| Dec 31, 2024 | 146.04% |
| Sep 30, 2024 | -49.41% |
| Jun 30, 2024 | 357.05% |
| Mar 31, 2024 | 713.46% |
| Dec 31, 2023 | 54,863.75% |
| Sep 30, 2023 | 176,298.94% |
| Jun 30, 2023 | 2,606.06% |
| Mar 31, 2023 | 287.05% |
| Dec 31, 2022 | -96.55% |
| Sep 30, 2022 | -95.37% |
| Jun 30, 2022 | -61.55% |
| Mar 31, 2022 | 154.22% |
| Dec 31, 2021 | 6,007.89% |
| Sep 30, 2021 | 5,242.11% |
| Jun 30, 2021 | 3,965.79% |